Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment

Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment

US Patent 10041947 · Granted Aug 7, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor2018
Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor2018
Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor2018
Method for linking and characterising linked nucleic acids, E.G. antibody encodi2017
Prostate cancer markers2017
Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus2016
Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus2016
Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus2016
Markers for the diagnosis of celiac disease2015
Method for differentiation of polynucleotide strands2015
Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor2015
Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor2015